Om Dhingra PhD

Dr. Dhingra has more than 20 years experience in pharmaceutical industry leading discovery & development of drugs for Metabolic, Viral, Oncology and Diseases of Aging. He founded Differential Drug Development Associates (DDDA) in 2008, and developed a drug delivery technology for enhancing solubility, metabolic stability, and absorption of lipophilic compounds. In 2009, he founded SOV Therapeutics, Inc. focusing on utilizing the delivery technology for the development of a new standard of care in testosterone replacement therapy for adults. Prior to founding DDDA and SOV Therapeutics, Inc., he worked for GSK and heritage companies for 17 years starting in 1991 as Head of Structural Chemistry and progressed to Vice President and Head of Preclinical Drug Discovery and Development for the Center Of Excellence in Metabolic Diseases.